Irreversible immunoexpression of matrix metalloproteinase-9 in proximal tubular epithelium of renal allografts with acute rejection

Clinical Transplantation

Volumn 25, Issue 3, 2011, Pages

  Kitajima, Kazuki ^a   Koike, Junki ^a   Nozawa, Shiari ^a   Yoshiike, Miki ^a   Takagi, Masayuki ^a   Chikaraishi, Tatsuya ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute rejection; Immunohistochemistry; Matrix metalloproteinase 9; Proximal tubular epithelium; Renal allograft; Tubulitis

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; GELATINASE B; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ACUTE TOXICITY; ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ATROPHY; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE EPITHELIUM; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; NEPHROTOXICITY; OLIGURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; QUANTITATIVE ANALYSIS; SCHOOL CHILD; TUBULITIS; WEIGHT GAIN;

ADOLESCENT; ADULT; CHILD; COMBINED MODALITY THERAPY; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROGNOSIS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 79958735589     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01421.x     Document Type: Article

References (24)

1. Solez K, Colvin RB, Racusen LC et al. Banff '05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007: 7: 518.
2. Solez K, Colvin RB, Racusen LC et al. Banff '07 classification of renal allograft pathology: updates and directions. Am J Transplant 2008: 8: 753.
3. Solez K. History of Banff classification of allograft pathology as it approaches its 20th year. Curr Opin Organ Transplant 2010: 15: 49.
4. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991: 64: 327.
5. Brown PD, Giavazzi R. Matrix metalloproteinase inhibition: a review of anti-tumor activity. Ann Oncol 1995: 6: 967.
6. Lenz O, Elliot SJ, Stetler-Stevenson WG. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 2000: 11: 574.
7. Camp TM, Smiley LY, Hayden MR, Tyagi SC. Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats. J Hypertens 2003: 21: 1719.
8. Ermolli M, Schumacher M, Lods N, Hmaoud M, Marti HP. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection. Transpl Immunol 2003: 11: 137.
9. Berthier CC, Lods N, Joosten SA et al. Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets. Kidney Int 2006: 69: 358.
10. Lutz J, Yao Y, Song E et al. Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats. Transplantation 2005: 79: 655.
11. Rödder S, Scherer A, Raulf F et al. Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes. Am J Transplant 2009: 9: 517.
12. Cheng S, Lovett DH. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 2003: 162: 1937.
13. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006: 69: 213.
14. Wa{ogonek}growska-Danilewicz M, Danilewicz M. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal graft. Pol J Pathol 2008: 59: 189.
15. Rödder S, Scherer A, Körner M et al. Meta-analyses qualify metzincins and related genes as acute rejection markers in renal transplant patients. Am J Transplant 2010: 10: 286.
16. Koide H, Nakamura T, Ebihara I, Tomino Y. Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy. Am J Kidney Dis 1996: 28: 32.
17. Marti HP, McNeil L, Thomas G, Davies M, Lovett DH. Molecular characterization of a low-molecular-mass matrix metalloproteinases secreted by glomerular mesangial cells as PUMP-1. Biochem J 1992: 285: 899.
18. Ebihara I, Nakamura T, Shimada N, Koide H. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1998: 32: 544.
19. Wa{ogonek}growska-Danilewicz M, Danilewicz M. Dysregulation of immunoexpression of matrix metalloproteinases in renal chronic allograft injury. Pol J Pathol 2009: 2: 88.
20. Tan TK, Zheng G, Hsu TT et al. Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol 2010: 176: 1256.
21. Nee LE, McMorrow T, Cambell E, Slattery C, Ryan MP. TNF-α and IL-β-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells. Kidney Int 2004: 66: 1376.
22. D'Amico G. Tubulo-interstitial damage in glomerular diseases: its role in the progression of renal damage. Nephrol Dial Transplant 1998: 13 (Suppl. 1): 80.
23. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003: 349: 2326.
24. Striz I, Eliska K, Eva H et al. Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft. Immunol Lett 2005: 99: 30.